Dimitri Roumenov

558 total citations
9 papers, 431 citations indexed

About

Dimitri Roumenov is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Dimitri Roumenov has authored 9 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Dimitri Roumenov's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Dimitri Roumenov is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). Dimitri Roumenov collaborates with scholars based in France, United States and Italy. Dimitri Roumenov's co-authors include Michel Bottlaender, Héric Valette, Frédéric Dollé, Michèle Ottaviani, Christine Coulon, Marie‐Claude Grégoire, Barbara Steinborn, Françoise Hinnen, Marcel Ricard and Fabienne Picard and has published in prestigious journals such as Brain, Cerebral Cortex and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dimitri Roumenov

9 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dimitri Roumenov France 9 210 185 90 78 44 9 431
Zhi-Ying Yang United States 7 126 0.6× 244 1.3× 105 1.2× 67 0.9× 38 0.9× 8 455
Denis Fournier France 9 64 0.3× 148 0.8× 71 0.8× 62 0.8× 61 1.4× 15 339
B Roth United States 7 290 1.4× 307 1.7× 28 0.3× 46 0.6× 47 1.1× 11 547
Anne B. Need United States 11 237 1.1× 316 1.7× 53 0.6× 43 0.6× 119 2.7× 15 529
V. Haroutunian United States 6 140 0.7× 80 0.4× 43 0.5× 117 1.5× 69 1.6× 8 423
Jasper van der Aart United Kingdom 9 96 0.5× 168 0.9× 75 0.8× 62 0.8× 87 2.0× 16 359
R. IYER United States 8 161 0.8× 319 1.7× 89 1.0× 97 1.2× 69 1.6× 16 486
Luis Gracia United States 8 288 1.4× 269 1.5× 30 0.3× 32 0.4× 43 1.0× 13 536
Stefano Aringhieri Italy 7 185 0.9× 125 0.7× 28 0.3× 148 1.9× 35 0.8× 7 453
Frederik C. Grønvald Denmark 8 230 1.1× 314 1.7× 32 0.4× 83 1.1× 35 0.8× 10 420

Countries citing papers authored by Dimitri Roumenov

Since Specialization
Citations

This map shows the geographic impact of Dimitri Roumenov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Roumenov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Roumenov more than expected).

Fields of papers citing papers by Dimitri Roumenov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Roumenov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Roumenov. The network helps show where Dimitri Roumenov may publish in the future.

Co-authorship network of co-authors of Dimitri Roumenov

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Roumenov. A scholar is included among the top collaborators of Dimitri Roumenov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Roumenov. Dimitri Roumenov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zanotti‐Fregonara, Paolo, Claire Leroy, Gaia Rizzo, et al.. (2014). Imaging of monoamine oxidase-A in the human brain with [11C]befloxatone. Nuclear Medicine Communications. 35(12). 1254–1261. 10 indexed citations
2.
Zanotti‐Fregonara, Paolo, Claire Leroy, Dimitri Roumenov, et al.. (2013). Kinetic analysis of [11C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A. EJNMMI Research. 3(1). 78–78. 14 indexed citations
3.
Leroy, Claire, Véronique Bragulat, Ivan Berlin, et al.. (2009). Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone. Journal of Clinical Psychopharmacology. 29(1). 86–88. 42 indexed citations
4.
Picard, Fabienne, Denis Servent, Wadad Saba, et al.. (2006). Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 129(8). 2047–2060. 123 indexed citations
5.
Dehaene, Severine, et al.. (2006). Dynamics of Prefrontal and Cingulate Activity during a Reward-Based Logical Deduction Task. Cerebral Cortex. 17(4). 749–759. 25 indexed citations
6.
Gallezot, Jean‐Dominique, Michel Bottlaender, Marie‐Claude Grégoire, et al.. (2005). In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.. PubMed. 46(2). 240–7. 77 indexed citations
7.
Bottlaender, Michel, Frédéric Dollé, Ilonka Guenther, et al.. (2003). Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone. Journal of Pharmacology and Experimental Therapeutics. 305(2). 467–473. 23 indexed citations
8.
Bottlaender, Michel, Héric Valette, Dimitri Roumenov, et al.. (2003). Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers.. PubMed. 44(4). 596–601. 71 indexed citations
9.
Crevoisier, C, et al.. (1997). Food increases the bioavailability of mefloquine. European Journal of Clinical Pharmacology. 53(2). 135–139. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi-Ying Yang Breakdown of academic impact, for papers by Denis Fournier Breakdown of academic impact, for papers by B Roth Breakdown of academic impact, for papers by Anne B. Need Breakdown of academic impact, for papers by V. Haroutunian Breakdown of academic impact, for papers by Jasper van der Aart Breakdown of academic impact, for papers by R. IYER Breakdown of academic impact, for papers by Luis Gracia Breakdown of academic impact, for papers by Stefano Aringhieri Breakdown of academic impact, for papers by Frederik C. Grønvald
Rankless by CCL
2026